Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.7435
-0.0197-2.58%
Volume:39.19K
Turnover:29.53K
Market Cap:62.80M
PE:-0.25
High:0.7600
Open:0.7600
Low:0.7302
Close:0.7632
Loading ...

Sutro Biopharma Inc. Faces Possible NASDAQ Delisting Over $1 Minimum Bid Price Non-Compliance

Reuters
·
26 Jun

Sutro Biopharma Raised to Overweight From Neutral by Piper Sandler

Dow Jones
·
17 Jun

Sutro Biopharma Inc : Piper Sandler Raises to Overweight From Neutral

THOMSON REUTERS
·
16 Jun

Sutro Biopharma upgraded to Overweight from Neutral at Piper Sandler

TIPRANKS
·
16 Jun

Sutro Biopharma Inc. Conducted Annual Stockholders Meeting

Reuters
·
11 Jun

Sutro Biopharma Appoints Greg Chow as New Chief Financial Officer, Effective June 2025

Reuters
·
02 Jun

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer

THOMSON REUTERS
·
02 Jun

Sutro Biopharma Is Maintained at Underperform by B of A Securities

Dow Jones
·
20 May

Piper Sandler Remains a Hold on Sutro Biopharma (STRO)

TIPRANKS
·
09 May

TD Cowen Remains a Buy on Sutro Biopharma (STRO)

TIPRANKS
·
09 May

Sutro Biopharma Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
09 May

Sutro Biopharma Q1 EPS $(0.91) Misses $(0.71) Estimate, Sales $17.40M Beat $11.61M Estimate

Benzinga
·
09 May

BRIEF-Sutro Biopharma Q1 Revenue USD 17.399 Million

Reuters
·
09 May

Sutro Biopharma Q1 Basic EPS USD -0.91

THOMSON REUTERS
·
09 May

Sutro Biopharma Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow Jones
·
29 Apr

Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls

TipRanks
·
18 Mar

Sutro Biopharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
17 Mar

Sutro Biopharma, Inc. : H.c. Wainwright Cuts Target Price to $2 From $12

THOMSON REUTERS
·
17 Mar

Oppenheimer Downgrades Sutro Biopharma to Market Perform From Outperform

MT Newswires Live
·
17 Mar

Deutsche Bank Adjusts Sutro Biopharma Price Target to $5 From $10, Maintains Buy Rating

MT Newswires Live
·
17 Mar